Medicine guide

Bimzelx 160 mg

As listed in the register: Bimzelx 160 mg, solution injectable en seringue préremplie

160 mg ·

  • Prescription only
  • Cancer treatments and immune-system medicines
Active substance
Bimekizumabum
Made by
UCB-Pharma SA

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Psoriasis en plaques chez l'adulte, arthrite psoriasique chez l'adulte, Spondylarthrite axiale chez l'adulte, Hidradénite suppurée

From the official label · 2026-09-30 · Swissmedic

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byUCB-Pharma SA
Active substanceBimekizumabum
Used inCancer treatments and immune-system medicines
Strength160 mg
ClassificationL04AC21 · Cancer treatments and immune-system medicines
Dispensing (as stated by the register)Abgabekategorie B
Name in the registerBimzelx 160 mg, solution injectable en seringue préremplie
Packs1 Fertigspritze(n) · 2 Fertigspritze(n)
Zulassungsnummer68548
Dosisstärke1

Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician

Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Other strengths and forms

2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

  • 2 products
    • 160 mg2

      160 mg · 2 companies

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.